Lumos Pharma Stock Forecast for 2023 - 2025 - 2030
Updated on 05/21/2024
Lumos Pharma Stock Forecast and Price Target
Lumos Pharma's stock is projected to advance by 777.86% from the previous closing price if it reaches the average target of $23.00 by the year's end, as two reputable analysts recently projected. This potential upside is calculated on a high-end estimate of $28.00 and a low-end estimate of $16.00.
777.86% Upside
Lumos Pharma Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Lumos Pharma's Price has grown from $0.00 to $0.00 – a 100.00% increase. Next year, analysts are expecting Fair Value to reach $2.80 – an increase of 100.00%. Over the next seven years, the forecast is for Fair Value to grow by 100.00%.
Lumos Pharma Revenue Forecast for 2023 - 2025 - 2030
In the last three years, Lumos Pharma's Revenue has grown from $170.00k to $2.05M – a 1105.88% increase. According to 4 prominent analysts, Lumos Pharma's Revenue will fall by 80.00% in the next year, reaching $410.00k. Over the next seven years, the forecast is for Revenue to grow by 27234.15%.
Lumos Pharma EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Lumos Pharma's EBITDA has grown, rising from $-25.72M to $-36.57M – a growth of 42.19%. In the next year, 0 analysts estimate that Lumos Pharma's EBITDA will decrease by 10.87%, reaching $-32.59M. According to professional forecasts, in 2030, Lumos Pharma's EBITDA will decrease by 10.37%, reaching $-32.78M.
Lumos Pharma EBIT Forecast for 2023 - 2025 - 2030
Lumos Pharma's EBIT has grown In the last three years, rising from $-26.30M to $-36.61M – a growth of 39.20%. In the next year, analysts believe that EBIT will reach $-46.65M – an increase of 27.42%. Professionals believe that By 2030, Lumos Pharma's EBIT will fall to $401.27M – a 1196.07% decrease from its current value.
Lumos Pharma EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Lumos Pharma's EPS has grown from $-0.93 to $0.00 – a 100.00% increase. Next year, analysts are expecting EPS to reach $-3.94 – an increase of 100.00%. Over the next seven years, the forecast is for EPS to grow by 100.00%.